(Audio) UroPatient Episode 13: iTind for BPH

iTind, a novel treatment for benign prostatic hyperplasia (BPH), is garnering attention for its minimally invasive approach and promising outcomes. This innovative device employs temporary implantation of shape-memory nitinol implants into the prostatic urethra, inducing controlled mechanical stress on the tissue. Over the course of several weeks, the implants gradually expand and remodel the prostatic tissue, resulting in a reduction of urethral obstruction and improvement in urinary flow. Unlike traditional surgical procedures such as transurethral resection of the prostate (TURP) or laser ablation techniques, iTind does not involve tissue removal or thermal energy, reducing the risk of post-operative complications and preserving sexual function. *The information provided on the site is for educational purposes only, and does not substitute for professional medical advice. Consult a medical professional or healthcare provider if you are seeking medical advice, diagnoses, or treatment. #itind #bph #prostate